Recent government enforcement efforts in conflict of interest related to physician decision-making heighten the importance of developing and maintaining a robust conflict of interest (COI) disclosure process. To help health systems understand the expectations and adopt a proactive COI process to mitigate risk, PYA has released a new white paper: Under the Microscope: Mitigating Risk Through Robust Conflict of Interest Processes for Health Systems.
While conflicts of interest can occur in a variety of settings and circumstances, three common areas include medical device product selection, drug formulary selection, and clinical research. In the new PYA white paper, experts discuss the three areas, review governmental enforcement and related actions, provide guidance for managing a potential conflict, and share PYA resources: Open Payments Dashboard and CMS Open Payments Registry Review Checklist.
PYA is ready to help your organization. If you have questions about compliance program best practices, compliance risk assessments, internal auditing and monitoring, or compliance work plans, we would be happy to assist. Please contact us at the e-mails below or at (800) 270-9629.
